Skip to main content
RecallRadar
FDAClass II

Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceut… Recalled: Failed Content Uniformity Specifications. Out of Specification for Assay during analysis…

Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx… was recalled on August 31, 2026 in cooperation with the U.S. Food and Drug Administration because failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at…

Is my unit affected?

Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5

Model, lot & date codes to check

Lot # AD48154, Exp: 4/30/2027.

Units affected: 65,328 50g jars

Where it was sold: Nationwide in the USA

Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.

What's the hazard?

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Class II means the product might cause a temporary or medically reversible health problem; the chance of serious harm is remote.

Your remedy & how to claim it

Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.

Contact: Recalling firm: SUN PHARMA /TARO

Not sure what you're entitled to? Read our guide: what to do if your product is recalled.

Official recall notice

Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.

View official notice →

Get recall alerts

Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.

Double opt-in: we only email you after you confirm. No spam, ever.